Twist Bioscience Corp. (TWST)
150.31
-23.14
(-13.34%)
USD |
NASDAQ |
Oct 30, 16:00
152.02
+1.71
(+1.14%)
After-Hours: 20:00
Twist Bioscience Free Cash Flow : -93.22M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -93.22M |
| March 31, 2026 | -95.14M |
| December 31, 2025 | -86.72M |
| September 30, 2025 | -75.63M |
| June 30, 2025 | -68.71M |
| March 31, 2025 | -65.49M |
| December 31, 2024 | -68.39M |
| September 30, 2024 | -69.17M |
| June 30, 2024 | -74.94M |
| March 31, 2024 | -95.52M |
| December 31, 2023 | -128.84M |
| September 30, 2023 | -170.25M |
| June 30, 2023 | -164.88M |
| March 31, 2023 | -211.73M |
| December 31, 2022 | -232.70M |
| Date | Value |
|---|---|
| September 30, 2022 | -226.24M |
| June 30, 2022 | -251.40M |
| March 31, 2022 | -211.54M |
| December 31, 2021 | -170.18M |
| September 30, 2021 | -139.30M |
| June 30, 2021 | -123.84M |
| March 31, 2021 | -115.25M |
| December 31, 2020 | -143.71M |
| September 30, 2020 | -152.12M |
| June 30, 2020 | -151.95M |
| March 31, 2020 | -152.88M |
| December 31, 2019 | -116.06M |
| September 30, 2019 | -102.69M |
| June 30, 2019 | -93.19M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Intellia Therapeutics, Inc. | -348.69M |
| Beam Therapeutics, Inc. | -372.77M |
| 10X Genomics, Inc. | 121.44M |
| Moderna, Inc. | -1.244B |
| Prime Medicine, Inc. | -156.85M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.115M |
| Cash from Investing (Quarterly) | -10.20M |
| Cash from Financing (Quarterly) | 3.787M |
| Free Cash Flow Per Share (Quarterly) | -0.1386 |
| Free Cash Flow to Equity (Quarterly) | -6.397M |
| Free Cash Flow to Firm (Quarterly) | -8.648M |
| Free Cash Flow Yield | -1.01% |